Universitätsklinik Balgrist
Zurich, Switzerland
NCT Number: NCT03069404
The investigation is a multi-year observational study following the completion of the open-label, single dose Phase I/II study involving transplantation of allogeneic HuCNS-SC cells into 12 subjects with thoracic spinal cord injury.
Subjects will be monitored at routine intervals for safety and preliminary efficacy for 5 years post-transplantation of the Phase I/II investigation CL-N02-SC.
Looking for future studies?
Notify Me18 year–60 year
All sexes
Observational
Zurich, Switzerland
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 36 months after transplantation of HuCNS-SC®
Evidence of improvement in ASIA impairment scale as confirmed by neurological examination
Looking for future studies?
Notify MeUniversity of Zurich
Other
INSTrUCT-SCI: INdependent Observational STUdy of Cell Transplantation in SCI, an Investigator Initiated Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04721717
Amyotrophic Lateral Sclerosis, Autoimmune Diseases
Birmingham, Alabama, United States
View Trial DetailsNCT07128901
Central Nervous System Diseases, Nervous System Diseases
Atlanta, Georgia, United States
View Trial DetailsNCT04493372
Autonomic Dysreflexia, Autonomic Imbalance
Rochester, Minnesota, United States
View Trial DetailsNCT03736382
Apnea, Central Nervous System Diseases
Detroit, Michigan, United States
View Trial Details